Home/Recalls/CANADA-24494
Health CanadaGeneral Alert

Archived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrova...

Published: March 17, 2004Recall ID: 24494Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

Archived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia Trials

Additional Source Details

FieldValue
N I D24494
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/archived-important-drug-safety-information-zyprexa-olanzapine-and-cerebrovascular
IssueProduct safety
Title Archived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia Trials
Archived1
CategoryHealth products
Last updated2004-03-17
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert